Cannabinoid receptor 2 agonist ameliorates mesenteric angiogenesis and portosystemic collaterals in cirrhotic rats. (Q48740932)

15 February 2018

title

Cannabinoid receptor 2 agonist ameliorates mesenteric angiogenesis and portosystemic collaterals in cirrhotic rats. (English)

1 reference

15 February 2018

0 references

0 references

0 references

Hui-Chun Huang

1

1 reference

15 February 2018

Sun-Sang Wang

2

1 reference

15 February 2018

I-Fang Hsin

3

1 reference

15 February 2018

Ching-Chih Chang

4

1 reference

15 February 2018

Fa-Yauh Lee

5

1 reference

15 February 2018

Han-Chieh Lin

6

1 reference

15 February 2018

Chiao-Lin Chuang

7

1 reference

15 February 2018

Jing-Yi Lee

8

1 reference

15 February 2018

Hsian-Guey Hsieh

9

1 reference

15 February 2018

Shou-Dong Lee

10

1 reference

15 February 2018

language of work or name

English

0 references

publication date

6 June 2012

1 reference

15 February 2018

published in

Hepatology

1 reference

15 February 2018

volume

56

1 reference

15 February 2018

issue

1

1 reference

15 February 2018

page(s)

248-258

1 reference

15 February 2018

Beneficial effects of sorafenib on splanchnic, intrahepatic, and portocollateral circulations in portal hypertensive and cirrhotic rats

cites work

1 reference

The biology of vascular endothelial growth factor

21 January 2018

1 reference

Anti-VEGF receptor-2 monoclonal antibody prevents portal-systemic collateral vessel formation in portal hypertensive mice.

21 January 2018

1 reference

Structure of a cannabinoid receptor and functional expression of the cloned cDNA

21 January 2018

1 reference

Molecular characterization of a peripheral receptor for cannabinoids

21 January 2018

1 reference

Cannabinoids inhibit the vascular endothelial growth factor pathway in gliomas.

21 January 2018

1 reference

Role of prostacyclin in the splanchnic hyperemia contributing to portal hypertension.

21 January 2018

1 reference

Role of endothelial nitric oxide synthase in the development of portal hypertension in the carbon tetrachloride-induced liver fibrosis model.

21 January 2018

1 reference

The selective Cox-2 inhibitor Celecoxib suppresses angiogenesis and growth of secondary bone tumors: an intravital microscopy study in mice

21 January 2018

1 reference

In vivo angiogenesis in normal and portal hypertensive rats: role of basic fibroblast growth factor and nitric oxide

21 January 2018

1 reference

Nitric oxide synthase modulates angiogenesis in response to tissue ischemia

21 January 2018

1 reference

Endocannabinoids acting at vascular CB1 receptors mediate the vasodilated state in advanced liver cirrhosis

21 January 2018

1 reference

Portal hypertension after bile duct obstruction: effect of bile diversion on portal pressure in the rat.

21 January 2018

1 reference

Administration of N omega-nitro-L-arginine ameliorates portal-systemic shunting in portal-hypertensive rats.

21 January 2018

1 reference

The isolated perfused rat liver: conceptual and practical considerations

21 January 2018

1 reference

Immunohistochemical identification of an extracellular matrix scaffold that microguides capillary sprouting in vivo

21 January 2018

1 reference

Site-specific increases in peripheral cannabinoid receptors and their endogenous ligands in a model of neuropathic pain.

21 January 2018

1 reference

Identification and functional characterization of brainstem cannabinoid CB2 receptors

21 January 2018

1 reference

Cervical sympathectomy regulates expression of key angiogenic factors in the rat choroid.

21 January 2018

1 reference

Hemorrhagic shock-induced vascular hyporeactivity in the rat: relationship to gene expression of nitric oxide synthase, endothelin-1, and select cytokines in corresponding organs

21 January 2018

1 reference

A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding

21 January 2018

1 reference

Changes in interleukin-1 signal modulators induced by 3,4-methylenedioxymethamphetamine (MDMA): regulation by CB2 receptors and implications for neurotoxicity

21 January 2018

1 reference

CB1 receptor inhibition leads to decreased vascular AT1 receptor expression, inhibition of oxidative stress and improved endothelial function

21 January 2018

1 reference

Cannabinoid-induced mesenteric vasodilation through an endothelial site distinct from CB1 or CB2 receptors

21 January 2018

1 reference

Virodhamine relaxes the human pulmonary artery through the endothelial cannabinoid receptor and indirectly through a COX product

21 January 2018

1 reference

Differential effect of cannabinoid agonists and endocannabinoids on histamine release from distinct regions of the rat brain

21 January 2018

1 reference

Selective CB2 receptor agonism protects central neurons from remote axotomy-induced apoptosis through the PI3K/Akt pathway.

21 January 2018

1 reference

PECAM-1 (CD31) Cloning and Relation to Adhesion Molecules of the Immunoglobulin Gene Superfamily

21 January 2018

1 reference

Angiogenesis in chronic inflammatory liver disease

21 January 2018

1 reference

21 January 2018

1 reference

Regression of fibrosis after chronic stimulation of cannabinoid CB2 receptor in cirrhotic rats.

21 January 2018

1 reference

Inhibition of skin tumor growth and angiogenesis in vivo by activation of cannabinoid receptors

21 January 2018

1 reference

Ceramide: a new second messenger of cannabinoid action

21 January 2018

1 reference

Expression of central and peripheral cannabinoid receptors in human immune tissues and leukocyte subpopulations

21 January 2018

1 reference

Cyclo-oxygenase-2 enhances basic fibroblast growth factor-induced angiogenesis through induction of vascular endothelial growth factor in rat sponge implants

21 January 2018

1 reference

Involvement of cannabinoids in the cardioprotection induced by lipopolysaccharide

21 January 2018

1 reference

The hyperdynamic circulation of chronic liver diseases: from the patient to the molecule

21 January 2018

1 reference

Inhibition of tumor angiogenesis by cannabinoids

21 January 2018

1 reference

7 January 2021

Increased angiogenesis in portal hypertensive rats: role of nitric oxide

1 reference

7 January 2021

The porto-systemic collateral pattern in the rat. An angiographic and anatomical study after partial occlusion of the portal vein

1 reference

7 January 2021

Disturbances of structure and function in the liver as the result of biliary obstruction

1 reference

7 January 2021

Local administration of WIN 55,212-2 reduces chronic granuloma-associated angiogenesis in rat by inhibiting NF-κB activation

1 reference

7 January 2021

Endogenous interleukin-1 receptor antagonist mediates anti-inflammatory and neuroprotective actions of cannabinoids in neurons and glia.

1 reference

7 January 2021

Contribution of portal systemic shunt to Kupffer cell dysfunction in obstructive jaundice

1 reference

7 January 2021

Identifiers

DOI

10.1002/HEP.25625

1 reference

15 February 2018

PubMed ID

22290687

1 reference

15 February 2018